Mustang Bio, Inc.
MBIO
$1.17
-$0.03-2.47%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 90.03% | 89.78% | 73.28% | 69.47% | 62.61% |
| Total Depreciation and Amortization | -89.56% | -88.30% | -91.86% | -63.01% | -58.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | -54.55% | -45.76% | -0.35% | 1.74% | -49.10% |
| Change in Net Operating Assets | -208.53% | -258.79% | 131.30% | 123.96% | 370.37% |
| Cash from Operations | 66.74% | 75.93% | 79.78% | 76.94% | 71.02% |
| Capital Expenditure | -- | -- | -- | -- | 76.74% |
| Sale of Property, Plant, and Equipment | -- | -80.58% | -80.58% | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | 3,983.33% | -80.32% | -80.21% | -- | -100.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 89.46% | 42.40% | 306.39% | 150.92% | 3,036.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -41.63% | -40.67% | -40.67% | -40.67% | -14,633.33% |
| Cash from Financing | 89.23% | 40.02% | 172.34% | 143.19% | 134.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 335.25% | 169.74% | 121.91% | 99.79% | 92.19% |